Jul 27, 2022 / 11:15PM GMT
Operator
Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results Conference Call. (Operator Instructions).
I would now like to hand the conference over to Michael Bassett, Senior Vice President of Corporate and Strategic Development. Please go ahead.
Michael John Bassett - ImpediMed Limited - SVP of Corporate & Strategic Development
Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 30 June 2022. Joining us on the call today is Don Williams, the Chairman of ImpediMed; Dave Anderson, the newly appointed Interim CEO; and Tim Cruickshank, our CFO. We'll be referencing the 4C and speaking from the quarterly activity report we launched this morning Australian time. The presentation is a summary of the more detailed 4C, and the presentation can be found on the ASX website.
After our remarks, we'll be taking questions. Firstly, I'd like to introduce Don Williams, the Chairman of ImpediMed, for an update on the recent management changes and
Full Year 2022 ImpediMed Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
